Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aptose Biosciences Inc.
DescriptionDual targeting bromodomain containing 4 (BRD4) and Janus kinase-2 (JAK-2) inhibitor
Molecular Target Bromodomain containing 4 (BRD4) ; Janus kinase-2 (JAK-2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors and hematologic malignancies
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today